# A Study to Investigate Safety and Efficacy of KB111 for the Treatment of Hailey-Hailey Disease

> **NCT07717346** · EARLY_PHASE1 · RECRUITING · sponsor: **Krystal Biotech, Inc.** · enrollment: 7 (estimated)

## Conditions studied

- Hailey Hailey Disease
- Skin Diseases
- Lesion Skin

## Interventions

- **BIOLOGICAL:** KB111

## Key facts

- **NCT ID:** NCT07717346
- **Lead sponsor:** Krystal Biotech, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-05-06
- **Primary completion:** 2026-11
- **Final completion:** 2026-12
- **Target enrollment:** 7 (ESTIMATED)
- **Last updated:** 2026-07-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07717346

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07717346, "A Study to Investigate Safety and Efficacy of KB111 for the Treatment of Hailey-Hailey Disease". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07717346. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*